Intézmény

Dudley Group NHS Foundation Trust

Dudley, Egyesült KirályságHonlap

6futó vizsgálat
5lezárt vizsgálat
1853publikáció (OpenAlex)

Futó vizsgálatok

Fut, nem toboroz
A Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque Psoriasis
NCT06934226· 3. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Selection in Adults With CROHN's Disease
NCT07363044· Alimentiv Inc.· Forrás
Fut, nem toboroz
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)
NCT06516965· 3. fázis· Incyte Corporation· Forrás
Fut, nem toboroz
A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease.
NCT06063967· 3. fázis· AbbVie· Forrás
Toboroz
Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)
NCT03573089· The University of Queensland· Forrás
Fut, nem toboroz
A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433
NCT03345823· 3. fázis· AbbVie· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

Crohn-betegség1 toboroz
Krónikus vesebetegség1 toboroz

Lezárt vizsgálatok

Lezárult
Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis
NCT04036435· 3. fázis· Bristol-Myers Squibb· Forrás
Lezárult
Observational Study of Patients With Moderate to Severe Chronic Plaque Psoriasis
NCT03982394· AbbVie· Forrás
Lezárult
A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis
NCT03915964· 4. fázis· Eli Lilly and Company· Forrás
Lezárult
Stopping Aminosalicylate Therapy in Inactive Crohn's Disease
NCT03261206· 4. fázis· Alimentiv Inc.· Forrás
Lezárult
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
NCT01848561· AbbVie· Forrás

Regiszterbeli névváltozatok (6)

A vizsgálati regiszterek ezeken a neveken tartják nyilván az intézményt. Minden sor egy regiszterbejegyzés: a címe és az alatta nyilvántartott vizsgálatok.

The Dudley Group Nhs Foundation Trust
Dudley, DY1 2HQ
5 vizsgálat
Dudley Group NHS Foundation Trust
Dudley, DY1 2HQ
2 vizsgálat
- NCT06934226A Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque Psoriasis
- NCT03261206Stopping Aminosalicylate Therapy in Inactive Crohn's Disease
The Dudley Group NHS Foundation Trust /ID# 164119
Dudley, DY1 2HQ
1 vizsgálat
- NCT01848561A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
The Dudley Group NHS Foundation Trust /ID# 169057
Dudley, DY1 2HQ
1 vizsgálat
- NCT03345823A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433
The Dudley Group NHS Foundation Trust /ID# 215839
Dudley, DY1 2HQ
1 vizsgálat
- NCT03982394Observational Study of Patients With Moderate to Severe Chronic Plaque Psoriasis
The Dudley Group NHS Foundation Trust /ID# 258681
Dudley, DY1 2HQ
1 vizsgálat
- NCT06063967A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease.

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

Giant cell arteritis3 munka · 0 vizsgálat

Intézményadatok: ROR 014hmqv77 (CC0-1.0)Frissítve: 2026. nov. 14.

Hibát jelzek